Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022146834> ?p ?o ?g. }
- W2022146834 endingPage "1156" @default.
- W2022146834 startingPage "1150" @default.
- W2022146834 abstract "ObjectivesAortic stenosis is one of the most common forms of acquired valvular heart disease in adults, and the proportion of patients unsuitable for conventional surgery is increasing. Consequently, the development of new less-invasive techniques to treat severe aortic stenosis is crucially important. Current experience in percutaneous aortic valve replacement is limited to a few groups, and the search for an optimal technique continues. We report our experience with retrograde endovascular bioprosthesis implantation with brief cardiopulmonary bypass support in high-risk older patients.MethodsThe CoreValve pericardial bioprosthesis (CoreValve, Inc, Paris, France) is sutured on a nitinol frame and delivered in a 21F catheter. All procedures were performed under femoro–femoral cardiopulmonary bypass support consisting of an aortic balloon valvuloplasty followed by prosthesis deployment within the aortic annulus under fluoroscopy. Ten high-risk surgical patients underwent percutaneous valve replacement.ResultsImmediate improvement in aortic valve function was observed in all patients. The aortic valve area increased from 0.57 ± 0.19 to 1.2 ± 0.35 cm2 (P = .00001), the mean transaortic valve gradient decreased from 51 ± 19 to 11 ± 3 mm Hg (P < .001). The 30-day mortality was 20%: one patient died 5 days after the procedure of a massive ischemic stroke and 1 patient died at 20 days of a hemorrhagic stroke. The median New York Heart Association functional class improved from III to II (P = .01).ConclusionsAortic valve replacement with the CoreValve bioprosthesis can be performed with favorable early technical results in high-risk patients. However, the morbidity and short-term mortality of such procedures remain significant. Aortic stenosis is one of the most common forms of acquired valvular heart disease in adults, and the proportion of patients unsuitable for conventional surgery is increasing. Consequently, the development of new less-invasive techniques to treat severe aortic stenosis is crucially important. Current experience in percutaneous aortic valve replacement is limited to a few groups, and the search for an optimal technique continues. We report our experience with retrograde endovascular bioprosthesis implantation with brief cardiopulmonary bypass support in high-risk older patients. The CoreValve pericardial bioprosthesis (CoreValve, Inc, Paris, France) is sutured on a nitinol frame and delivered in a 21F catheter. All procedures were performed under femoro–femoral cardiopulmonary bypass support consisting of an aortic balloon valvuloplasty followed by prosthesis deployment within the aortic annulus under fluoroscopy. Ten high-risk surgical patients underwent percutaneous valve replacement. Immediate improvement in aortic valve function was observed in all patients. The aortic valve area increased from 0.57 ± 0.19 to 1.2 ± 0.35 cm2 (P = .00001), the mean transaortic valve gradient decreased from 51 ± 19 to 11 ± 3 mm Hg (P < .001). The 30-day mortality was 20%: one patient died 5 days after the procedure of a massive ischemic stroke and 1 patient died at 20 days of a hemorrhagic stroke. The median New York Heart Association functional class improved from III to II (P = .01). Aortic valve replacement with the CoreValve bioprosthesis can be performed with favorable early technical results in high-risk patients. However, the morbidity and short-term mortality of such procedures remain significant." @default.
- W2022146834 created "2016-06-24" @default.
- W2022146834 creator A5000266337 @default.
- W2022146834 creator A5019447425 @default.
- W2022146834 creator A5029542482 @default.
- W2022146834 creator A5029829293 @default.
- W2022146834 creator A5033090327 @default.
- W2022146834 creator A5047341367 @default.
- W2022146834 creator A5052123873 @default.
- W2022146834 creator A5052883470 @default.
- W2022146834 creator A5056876246 @default.
- W2022146834 creator A5062232887 @default.
- W2022146834 date "2007-11-01" @default.
- W2022146834 modified "2023-10-16" @default.
- W2022146834 title "Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis" @default.
- W2022146834 cites W1505140059 @default.
- W2022146834 cites W1625132030 @default.
- W2022146834 cites W1964589386 @default.
- W2022146834 cites W1976669848 @default.
- W2022146834 cites W1985120128 @default.
- W2022146834 cites W1996007106 @default.
- W2022146834 cites W2007754522 @default.
- W2022146834 cites W2016785465 @default.
- W2022146834 cites W2033527002 @default.
- W2022146834 cites W2049670131 @default.
- W2022146834 cites W2099772090 @default.
- W2022146834 cites W2103009827 @default.
- W2022146834 cites W2112050863 @default.
- W2022146834 cites W2120508829 @default.
- W2022146834 cites W2122694177 @default.
- W2022146834 cites W2124968972 @default.
- W2022146834 cites W2148154533 @default.
- W2022146834 cites W2151892460 @default.
- W2022146834 cites W2290788483 @default.
- W2022146834 doi "https://doi.org/10.1016/j.jtcvs.2007.07.031" @default.
- W2022146834 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17976442" @default.
- W2022146834 hasPublicationYear "2007" @default.
- W2022146834 type Work @default.
- W2022146834 sameAs 2022146834 @default.
- W2022146834 citedByCount "57" @default.
- W2022146834 countsByYear W20221468342012 @default.
- W2022146834 countsByYear W20221468342013 @default.
- W2022146834 countsByYear W20221468342014 @default.
- W2022146834 countsByYear W20221468342015 @default.
- W2022146834 countsByYear W20221468342016 @default.
- W2022146834 countsByYear W20221468342017 @default.
- W2022146834 crossrefType "journal-article" @default.
- W2022146834 hasAuthorship W2022146834A5000266337 @default.
- W2022146834 hasAuthorship W2022146834A5019447425 @default.
- W2022146834 hasAuthorship W2022146834A5029542482 @default.
- W2022146834 hasAuthorship W2022146834A5029829293 @default.
- W2022146834 hasAuthorship W2022146834A5033090327 @default.
- W2022146834 hasAuthorship W2022146834A5047341367 @default.
- W2022146834 hasAuthorship W2022146834A5052123873 @default.
- W2022146834 hasAuthorship W2022146834A5052883470 @default.
- W2022146834 hasAuthorship W2022146834A5056876246 @default.
- W2022146834 hasAuthorship W2022146834A5062232887 @default.
- W2022146834 hasBestOaLocation W20221468341 @default.
- W2022146834 hasConcept C126322002 @default.
- W2022146834 hasConcept C127413603 @default.
- W2022146834 hasConcept C141071460 @default.
- W2022146834 hasConcept C164705383 @default.
- W2022146834 hasConcept C176752191 @default.
- W2022146834 hasConcept C2776570981 @default.
- W2022146834 hasConcept C2778789114 @default.
- W2022146834 hasConcept C2778881276 @default.
- W2022146834 hasConcept C2779040412 @default.
- W2022146834 hasConcept C2779736815 @default.
- W2022146834 hasConcept C2780007028 @default.
- W2022146834 hasConcept C2780026749 @default.
- W2022146834 hasConcept C2780645631 @default.
- W2022146834 hasConcept C2780714102 @default.
- W2022146834 hasConcept C2780813298 @default.
- W2022146834 hasConcept C2781414266 @default.
- W2022146834 hasConcept C2781436128 @default.
- W2022146834 hasConcept C71924100 @default.
- W2022146834 hasConcept C78519656 @default.
- W2022146834 hasConceptScore W2022146834C126322002 @default.
- W2022146834 hasConceptScore W2022146834C127413603 @default.
- W2022146834 hasConceptScore W2022146834C141071460 @default.
- W2022146834 hasConceptScore W2022146834C164705383 @default.
- W2022146834 hasConceptScore W2022146834C176752191 @default.
- W2022146834 hasConceptScore W2022146834C2776570981 @default.
- W2022146834 hasConceptScore W2022146834C2778789114 @default.
- W2022146834 hasConceptScore W2022146834C2778881276 @default.
- W2022146834 hasConceptScore W2022146834C2779040412 @default.
- W2022146834 hasConceptScore W2022146834C2779736815 @default.
- W2022146834 hasConceptScore W2022146834C2780007028 @default.
- W2022146834 hasConceptScore W2022146834C2780026749 @default.
- W2022146834 hasConceptScore W2022146834C2780645631 @default.
- W2022146834 hasConceptScore W2022146834C2780714102 @default.
- W2022146834 hasConceptScore W2022146834C2780813298 @default.
- W2022146834 hasConceptScore W2022146834C2781414266 @default.
- W2022146834 hasConceptScore W2022146834C2781436128 @default.
- W2022146834 hasConceptScore W2022146834C71924100 @default.
- W2022146834 hasConceptScore W2022146834C78519656 @default.
- W2022146834 hasIssue "5" @default.
- W2022146834 hasLocation W20221468341 @default.